Literature DB >> 27427919

The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.

A Rimondo1, R Crocchiolo1, J El-Cheikh2, S Bramanti1, A Granata3, S Furst3, B Sarina1, L Morabito1, R Devillier3, S Harbi3, B Mohty3, R Mineri4, C Faucher3, C Chabannon5,6,7, A Santoro1, D Blaise3,6,7, L Castagna1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27427919     DOI： 10.1038/bmt.2016.193

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

Review 1.  Polyomavirus BK infection in blood and marrow transplant recipients.

Authors:  L K Dropulic; R J Jones
Journal:  Bone Marrow Transplant       Date:  2007-10-22       Impact factor: 5.483

2.  Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients.

Authors:  A Ruggeri; G Roth-Guepin; G Battipaglia; A-C Mamez; F Malard; A Gomez; E Brissot; R Belhocine; A Vekhoff; S Lapusan; F Isnard; O Legrand; J Gozlan; D Boutolleau; T Ledraa; M Labopin; M-T Rubio; M Mohty
Journal:  Transpl Infect Dis       Date:  2015-11-25       Impact factor: 2.228

3.  In vitro effect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells.

Authors:  P D Acott; P A O'Regan; S H Lee; J F S Crocker
Journal:  Transpl Infect Dis       Date:  2008-07-28       Impact factor: 2.228

Review 4.  [Advances in haploidentical transplantation in hematological malignancies].

Authors:  Luca Castagna; Didier Blaise
Journal:  Bull Cancer       Date:  2012-12       Impact factor: 1.276

5.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

6.  BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts.

Authors:  G Giraud; P Priftakis; G Bogdanovic; M Remberger; M Dubrulle; A Hau; R Gutmark; J Mattson; B-M Svahn; O Ringden; J Winiarski; P Ljungman; T Dalianis
Journal:  Bone Marrow Transplant       Date:  2008-01-07       Impact factor: 5.483

7.  Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial.

Authors:  Scott R Solomon; Connie A Sizemore; Melissa Sanacore; Xu Zhang; Stacey Brown; H Kent Holland; Lawrence E Morris; Asad Bashey
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-01       Impact factor: 5.742

8.  Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.

Authors:  A Bedi; C B Miller; J L Hanson; S Goodman; R F Ambinder; P Charache; R R Arthur; R J Jones
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

9.  Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; S Cesaro; P Dreger; R F Duarte; C Dufour; J H F Falkenburg; D Farge-Bancel; A Gennery; N Kröger; F Lanza; A Nagler; A Sureda; M Mohty
Journal:  Bone Marrow Transplant       Date:  2015-02-02       Impact factor: 5.483

10.  Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.

Authors:  H H Hirsch; F Vincenti; S Friman; M Tuncer; F Citterio; A Wiecek; E H Scheuermann; M Klinger; G Russ; M D Pescovitz; H Prestele
Journal:  Am J Transplant       Date:  2012-11-08       Impact factor: 8.086
View more
  5 in total

1.  Effect of late-onset hemorrhagic cystitis on PFS after haplo-PBSCT.

Authors:  Hailong Yuan; Gang Chen; Jianhua Qu; Ruixue Yang; Maria Muhashi; Gulibadanmu Aizezi; Ming Jiang
Journal:  Open Med (Wars)       Date:  2021-10-05

2.  Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia.

Authors:  Eugenio Galli; Federica Sorà; Luca Di Gianfrancesco; Sabrina Giammarco; Elisabetta Metafuni; Maria Assunta Limongiello; Idanna Innocenti; Francesco Autore; Luca Laurenti; Patrizia Chiusolo; Andrea Bacigalupo; Simona Sica
Journal:  Support Care Cancer       Date:  2022-02-18       Impact factor: 3.359

3.  Outpatient haploidentical hematopoietic stem cell transplant using post-transplant cyclophosphamide and incidence of hemorrhagic cystitis.

Authors:  Cesar Homero Gutiérrez-Aguirre; Alejandra Celina Esparza-Sandoval; Alain Palomares-Leal; José Carlos Jaime-Pérez; David Gómez-Almaguer; Olga Graciela Cantú-Rodríguez
Journal:  Hematol Transfus Cell Ther       Date:  2020-12-04

4.  Incidence of late-onset hemorrhagic cystitis and its effect on PFS in acute leukemia patients after haplo-PBSCT: The 5-year single-center data.

Authors:  Hailong Yuan; Gang Chen; Jianli Xu; Ruixue Yang; Maria Muhashi; Gulibadanmu Aizezi; Ming Jiang
Journal:  Front Oncol       Date:  2022-07-15       Impact factor: 5.738

5.  Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults.

Authors:  Heather J Symons; Marianna Zahurak; Yilin Cao; Allen Chen; Kenneth Cooke; Christopher Gamper; Orly Klein; Nicolas Llosa; Elias T Zambidis; Richard Ambinder; Javier Bolaños-Meade; Ivan Borrello; Robert Brodsky; Amy DeZern; Ivana Gojo; Margaret Showel; Lode Swinnen; B Douglas Smith; Leo Luznik; Richard J Jones; Ephraim J Fuchs
Journal:  Blood Adv       Date:  2020-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.